United StatesTechnology

Boston Dynamics has launched its first commercially deployable Atlas humanoid robot at CES 2026.

Beverly Hills, California-based AXIL Brands (NYSE:AXIL) reported net sales of $8.1 million for its fiscal second quarter ended November 30, 2025, marking a 5.2% increase from the year-ago period.

Neogen (NASDAQ:NEOG) shares are in focus after the food and animal safety leader reported second-quarter revenue of $224.7 million, a 2.8% decline from the previous year.

TD SYNNEX (NYSE:SNX) today announced robust financial results for its fiscal fourth quarter ended November 30, 2025, demonstrating solid growth across key metrics.

Shares of software supply chain platform JFrog (NASDAQ:FROG) fell 4.7% in morning trading on January 8, 2026, as part of a broader market rotation out of the technology sector.

The decline came amid profit-taking in high-growth tech stocks following a strong recent rally, particularly in artificial-intelligence-related names.

Paramount (NASDAQ:PSKY) reaffirmed its $30-per-share cash offer for Warner Bros. Discovery on Thursday, resisting pressure to sweeten the deal even after WBD’s board dismissed the proposal as a risky "leveraged buyout."

RPM International (NYSE:RPM), a world leader in specialty coatings, sealants and building materials, reported record fiscal second-quarter sales of $1.91 billion for the period ended November 30, 2025, representing a 3.5% increase over the prior-year record.

Lindsay Corporation (NYSE:LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today reported its financial results for the first quarter of fiscal 2026, ended November 30, 2025.

Helen of Troy Limited (NASDAQ:HELE) reported third-quarter fiscal 2026 results that reflected ongoing headwinds in the consumer discretionary sector.

China is preparing to approve the import of Nvidia Corp.’s (NASDAQ:NVDA) H200 artificial intelligence chips for select commercial customers as soon as this quarter, according to people familiar with the matter.

NervGen Pharma Corp. (NASDAQ:NGEN) officially began trading on the Nasdaq Stock Market on January 8, marking a transition into a late-stage biopharmaceutical player.

Ceragon Networks (NASDAQ:CRNT) signaled a temporary shift in its 2025 finish line, projecting fourth-quarter revenue between $81 million and $83 million.